![Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma | Oncogenesis Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma | Oncogenesis](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41389-022-00394-7/MediaObjects/41389_2022_394_Fig1_HTML.png)
Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma | Oncogenesis
![PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma](https://i1.rgstatic.net/publication/356563513_BAF_complexes_drive_proliferation_and_block_myogenic_differentiation_in_fusion-positive_rhabdomyosarcoma/links/61a1c0777323543e210c1085/largepreview.png)
PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma
Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer | Journal of Medicinal Chemistry
![Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines](https://www.mdpi.com/cancers/cancers-14-00041/article_deploy/html/images/cancers-14-00041-g008.png)
Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines
![Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/dede4b9f-f2af-4915-9cc7-a4c5d69f6391/fx1_lrg.jpg)
Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development
![Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00136/asset/images/medium/jm1c00136_0002.gif)
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry
![Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology](https://pubs.acs.org/cms/10.1021/acssynbio.1c00606/asset/images/large/sb1c00606_0005.jpeg)
Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology
![BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27176-w/MediaObjects/41467_2021_27176_Fig1_HTML.png)
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications
![Frontiers | Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification Frontiers | Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification](https://www.frontiersin.org/files/Articles/1070338/fcell-10-1070338-HTML/image_m/fcell-10-1070338-t001.jpg)
Frontiers | Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification
![MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aan4470/asset/33b79a75-5694-4a27-931b-20f56bccb6fb/assets/graphic/aan4470-f1.jpeg)
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine
![Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/65e952ae-e757-4807-ad51-b3e27f846e35/adtp202100035-fig-0001-m.jpg)
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library
![Healthcare | Free Full-Text | Evaluating Long-Term Outcomes of a High School-Based Impaired and Distracted Driving Prevention Program Healthcare | Free Full-Text | Evaluating Long-Term Outcomes of a High School-Based Impaired and Distracted Driving Prevention Program](https://pub.mdpi-res.com/healthcare/healthcare-10-00474/article_deploy/html/images/healthcare-10-00474-g001.png?1646403108)